Show simple item record

dc.contributor.authorMauri, D.
dc.contributor.authorTzachanis, D.
dc.contributor.authorValachis, A.
dc.contributor.authorKamposioras, Konstantinos
dc.contributor.authorTolias, M.
dc.contributor.authorDambrosio, M.
dc.contributor.authorZarkavelis, G.
dc.contributor.authorGkoura, S.
dc.contributor.authorGazouli, I.
dc.contributor.authorDe Lorenzo, F.
dc.contributor.authorApostolidis, K.
dc.date.accessioned2020-10-06T13:33:46Z
dc.date.available2020-10-06T13:33:46Z
dc.date.issued2020en
dc.identifier.citationMiura K, Way M, Jiyad Z, Marquart L, Plasmeijer EI, Campbell S, et al. Omega-3 fatty acid intake and decreased risk of skin cancer in organ transplant recipients. Eur J Nutr. 2020.en
dc.identifier.pmid32862566en
dc.identifier.urihttp://hdl.handle.net/10541/623328
dc.description.abstractTo protect cancer patients from COVID-19 exposure, prioritization strategies are being implemented at global level. Measures include use of tele-health services, deferring elective surgeries, delaying non life-saving therapies, interrupting maintenance and supportive care regimens and suspending screening and regular follow-up visits. Nonetheless, the risk of infection may not always outweigh oncology treatment benefit. Lives of most oncology patients depend on their ability to receive medical, surgical and radiotherapy care. Postponing screening, follow-up and radical surgeries increase patients' risk of developing metastatic disease. A viral pandemic lasts long time and exhibits seasonal and geographical variations. Though vaccines will be available only in the 2021, a global, aggressive, all-embracing and protracted slowdown of oncologic activities will severely jeopardize patients' outcomes. A present international oncologists' panel, ECPC and FAVO, strongly suggest that Hospital measures in a specific geographical area/Nation should be in line with the local epidemic, and restrictions adopted should be adapted and stratified over time.en
dc.language.isoenen
dc.titleBehind the numbers and the panic of a viral pandemic: fixed restrictive oncology guidance may jeopardize patients' survivalen
dc.typeArticleen
dc.contributor.departmentDept of Medical Oncology, University of Ιoannina, Greece.en
dc.identifier.journalJournal of Buonen
dc.description.noteen]


This item appears in the following Collection(s)

Show simple item record